Home » Topics » Regulatory » Patents

Patents
RSS

Another series of DC-107 derivatives from Kyowa Hakko particularly useful as antitumor agents

Sep. 24, 1998

Hydroxamic acids as cancer cell differentiation inducers under study at Mitsui Chemicals

Sep. 24, 1998

Mitsui Chemicals prepares cell adhesion inhibitors

Sep. 24, 1998

More on NPY receptor antagonists developed at Banyu

Sep. 24, 1998

New MMP inhibitors in early development at Ono

Sep. 23, 1998

Banyu claims aminopyrazoles for eating disorders, diabetes

Sep. 23, 1998

Antiallergic and antiinflammatory agents developed at Takeda

Sep. 23, 1998

Kyowa Hakko studies DC-107 derivatives as antitumor/antibacterial agents

Sep. 23, 1998

Takeda describes preparation and use of inhibitors of steroid C17-20 lyase

Sep. 22, 1998

Collaborative work by Otsuka and Taiho leads to broad-spectrum, water-soluble cephems

Sep. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...